Novartis AG (NVSEF)
OTCMKTS · Delayed Price · Currency is USD
114.01
+1.58 (1.40%)
Aug 6, 2025, 3:31 PM EDT
Novartis AG Market Cap
Novartis AG has a market cap or net worth of $221.76 billion as of August 6, 2025. Its market cap has decreased by -2.89% in one year.
Market Cap
221.76B
Enterprise Value
247.38B
Revenue
55.19B
Ranking
n/a
PE Ratio
16.24
Stock Price
$114.01
Market Cap Chart
Since March 2, 1998, Novartis AG's market cap has increased from 127.35B to 221.76B, an increase of 74.14%. That is a compound annual growth rate of 2.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 228.98B | 17.12% |
| Dec 30, 2024 | 195.51B | -5.62% |
| Dec 29, 2023 | 207.17B | 6.54% |
| Dec 30, 2022 | 194.45B | -1.02% |
| Dec 30, 2021 | 196.46B | -8.76% |
| Dec 30, 2020 | 215.32B | 0.17% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 575.48M |
| Glass House Brands | 494.36M |
| Northwest Biotherapeutics | 366.60M |
| American Oncology Network | 330.70M |
| CytoDyn | 328.46M |